A Meta-analysis of Clinical Trials Evaluating the Impact of Bivalirudin-based Anticoagulation for Primary Percutaneous Coronary on Long-Term Mortality
PS Jagadish, FK Le, A Labroo, A Nasr… - Journal of …, 2021 - journals.lww.com
Bivalirudin and heparin are the principal anticoagulants used during primary percutaneous
coronary intervention (PCI) for patients experiencing ST-elevation myocardial infarctions …
coronary intervention (PCI) for patients experiencing ST-elevation myocardial infarctions …
Reperfusion After Fibrinolytic Therapy (RAFT): An open-label, multi-centre, randomised controlled trial of bivalirudin versus heparin in rescue percutaneous coronary …
A Faour, N Collins, T Williams, A Khan, CP Juergens… - Plos one, 2021 - journals.plos.org
Background The safety and efficacy profile of bivalirudin has not been examined in a
randomised controlled trial of patients undergoing rescue PCI. Objectives We conducted an …
randomised controlled trial of patients undergoing rescue PCI. Objectives We conducted an …
Real-world analysis of a Biolimus A9 polymer-free drug-coated stent with very short dual antiplatelet therapy in patients at high bleeding risk
C Grigorios, C Georgios, F Hannes, M Paul… - Herz, 2021 - search.proquest.com
Background Patients at high risk of bleeding requiring percutaneous coronary intervention
(PCI) need careful evaluation of both their thrombotic and their bleeding risks. In these …
(PCI) need careful evaluation of both their thrombotic and their bleeding risks. In these …
[HTML][HTML] Access-site vs non-access-site major bleeding and in-hospital outcomes among STEMI patients receiving primary PCI
Background Major bleeding (MB) is an independent predictor of mortality among ST-
elevation myocardial infarction (STEMI) patients undergoing primary percutaneous coronary …
elevation myocardial infarction (STEMI) patients undergoing primary percutaneous coronary …
Measuring Activated Clotting Time during Cardiac Catheterization and PCI: The Effect of the Sampling Site
JC Heemelaar, T Berkhout… - Journal of …, 2021 - Wiley Online Library
Background/Purpose. We aimed to investigate the influence of the sampling site on the
variability of ACT measurement. Activated clotting time (ACT) has been used for decades in …
variability of ACT measurement. Activated clotting time (ACT) has been used for decades in …
Cardiovascular medications
J Tamargo, NR Aggarwal, M Tamargo - Sex Differences in Cardiac …, 2021 - Elsevier
Clinical Case Unlabelled Image Download: Download full-size image A 69-year-old
Caucasian woman was admitted in the emergency department after 1 week with fever …
Caucasian woman was admitted in the emergency department after 1 week with fever …
Efficacy and safety of bivalirudin during percutaneous coronary intervention in chronic total occlusion: A retrospective study
Y Zhang, Y Zhang, C Chang, S Yan, Z Chen… - Clinical Therapeutics, 2021 - Elsevier
Purpose Bivalirudin as a thrombin inhibitor is proven to have a low risk of bleeding during
percutaneous coronary intervention (PCI). Some evidence indicates comparable …
percutaneous coronary intervention (PCI). Some evidence indicates comparable …
Anticoagulation in ST-Elevation Myocardial Infarction.
Intravenous anticoagulation is standard of care in the treatment of ST-elevation myocardial
infarction. Primary percutaneous coronary intervention is the most common reperfusion …
infarction. Primary percutaneous coronary intervention is the most common reperfusion …
Practicability of bivalirudin plus glycoprotein iib/iiia inhibitors in patients undergoing percutaneous coronary intervention: A meta-analysis
S Li, D Lv, C Liu, Y Jia - Clinical and Applied Thrombosis …, 2021 - journals.sagepub.com
A variety of antithrombotic drugs are used during percutaneous coronary interventions
(PCIs). We aimed to investigate the practicability of the use of bivalirudin and GPIs in …
(PCIs). We aimed to investigate the practicability of the use of bivalirudin and GPIs in …
Risk of heart failure following drug-eluting stent implantation in patients with non–ST–elevation myocardial infarction
CF Lin, YH Chang, FC Yu, CT Tsai, CC Chen, HY Liu… - Atherosclerosis, 2021 - Elsevier
Background and aims The association between implanted stent types and heart failure in
patients with non–ST-elevation myocardial infarction (NSTEMI) remains unknown. The …
patients with non–ST-elevation myocardial infarction (NSTEMI) remains unknown. The …